Monogram Health announced today that the organization has received HITRUST CSF® Certification, following a review of the company’s systems and controls for protecting electronic health records and other sensitive data.
“Strong information security controls are critical to population health management,” said Chris Chi, Monogram Health’s Chief Operating Officer. “Our company’s health plan clients and plan members entrust us with their data. HITRUST certification underscores our commitment to patient privacy and data security.”
Monogram uses its advanced, proprietary artificial intelligence systems to identify the potential care needs of patients with kidney disease. Monogram’s care team – made up of physicians, nurse care managers and social workers – partners with nephrologists to ensure medication and treatment compliance and adherence to evidence-based care pathways. The specialized care team also assesses health drivers, such as appropriate nutrition, exercise, and other social determinants of health, through regular visits with patients in their homes.
The HITRUST CSF® Certified Assurance Program verifies that the organization’s development, security, and compliance protocols meet key regulations and industry-defined requirements for data security and appropriate risk management. The certification encompasses HIPAA and numerous other federal and state regulations and standards for protecting sensitive patient data. Certification of Monogram Health’s cybersecurity effectiveness involved an end-to-end review of the company’s information technology systems, including its electronic care management system, software tools, cloud and data storage environments, servers, hardware, user workstations and encryption protocols.
“HITRUST is the industry gold standard for information security,” said David Hoffmann, Monogram Health’s Vice President of Information Technology. “Achieving HITRUST certification gives our clients peace of mind about their data and our safeguards to protect it.”
About Monogram Health
Monogram Health is a leading kidney-disease focused managed services company. It provides an innovative renal care model and data-driven array of care management solutions including complex case and disease management, utilization management and medication therapy management to transform the delivery of care received by patients living with chronic kidney and end-stage renal disease. Partnering with health plans, physician practices, dialysis providers and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized care management. Through the use of next generation artificial intelligence, evidence based criteria and personalized care planning, Monogram Health’s model seeks to delay the progression of the disease, promote a seamless transition to dialysis, palliative care and/or pre-emptive kidney transplant and optimize health outcomes for patients with end-stage renal disease. Based in Nashville, Tenn. and privately held by Frist Cressey Ventures and Norwest Venture Partners, Monogram Health currently operates its renal disease care management programs across the U.S. and has built a national network of nephrologists that includes hundreds of leading kidney care specialists. To learn more about Monogram Health, please visit here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201201005275/en/